Literature DB >> 25725986

Impact of storage conditions on metabolite profiles of sputum samples from persons with cystic fibrosis.

Jiangchao Zhao1, Charles R Evans2, Lisa A Carmody1, John J LiPuma3.   

Abstract

BACKGROUND: Although recent studies have begun to elucidate how airway microbial community structure relates to lung disease in cystic fibrosis (CF), microbial community activity and the host's response to changes in this activity are poorly understood. Metabolomic profiling provides a means to investigate microbial activity and human cell activity within diseased airways. However, variables in sample storage and shipping likely affect downstream analyses and standards for sample handling are lacking.
METHODS: We assessed the impact of sample storage conditions on liquid chromatography mass spectrometry analysis of CF sputum samples.
RESULTS: Significant changes in global metabolomic profiles occurred in samples stored at room temperature or at 4°C for longer than one day. Untargeted metabolomic profiles were stable in sputum samples stored at -20°C or -80°C for at least 28 days. Quorum sensing molecules and phenazines, both considered important to the in vivo activity of Pseudomonas during airway infection, were detected after sample storage at room temperature for five days.
CONCLUSIONS: Sputum samples can be stored at -20°C or -80°C for weeks with minimal effect on global metabolomic profiles. This observation provides guidance in designing metabolomic studies that have the potential to deepen our understanding of how airway microbial communities impact lung disease progression in CF.
Copyright © 2015 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cystic fibrosis; Metabolome; Sputum

Mesh:

Year:  2015        PMID: 25725986      PMCID: PMC4947390          DOI: 10.1016/j.jcf.2015.02.004

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  29 in total

1.  Changes in cystic fibrosis airway microbiota at pulmonary exacerbation.

Authors:  Lisa A Carmody; Jiangchao Zhao; Patrick D Schloss; Joseph F Petrosino; Susan Murray; Vincent B Young; Jun Z Li; John J LiPuma
Journal:  Ann Am Thorac Soc       Date:  2013-06

2.  Identifying decomposition products in extracts of cellular metabolites.

Authors:  Elizabeth Kimball; Joshua D Rabinowitz
Journal:  Anal Biochem       Date:  2006-08-14       Impact factor: 3.365

3.  Decade-long bacterial community dynamics in cystic fibrosis airways.

Authors:  Jiangchao Zhao; Patrick D Schloss; Linda M Kalikin; Lisa A Carmody; Bridget K Foster; Joseph F Petrosino; James D Cavalcoli; Donald R VanDevanter; Susan Murray; Jun Z Li; Vincent B Young; John J LiPuma
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

4.  Cross-platform comparison of methods for quantitative metabolomics of primary metabolism.

Authors:  Jörg Martin Büscher; Dominika Czernik; Jennifer Christina Ewald; Uwe Sauer; Nicola Zamboni
Journal:  Anal Chem       Date:  2009-03-15       Impact factor: 6.986

5.  Phenazine content in the cystic fibrosis respiratory tract negatively correlates with lung function and microbial complexity.

Authors:  Ryan C Hunter; Vanja Klepac-Ceraj; Magen M Lorenzi; Hannah Grotzinger; Thomas R Martin; Dianne K Newman
Journal:  Am J Respir Cell Mol Biol       Date:  2012-08-03       Impact factor: 6.914

6.  A bacterial cell to cell signal in the lungs of cystic fibrosis patients.

Authors:  David N Collier; Lisa Anderson; Susan L McKnight; Terry L Noah; Michael Knowles; Richard Boucher; Ute Schwab; Peter Gilligan; Everett C Pesci
Journal:  FEMS Microbiol Lett       Date:  2002-09-24       Impact factor: 2.742

7.  Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients.

Authors:  Jun Yang; Jason P Eiserich; Carroll E Cross; Brian M Morrissey; Bruce D Hammock
Journal:  Free Radic Biol Med       Date:  2012-05-08       Impact factor: 7.376

Review 8.  Directly sampling the lung of a young child with cystic fibrosis reveals diverse microbiota.

Authors:  Perry S Brown; Christopher E Pope; Robyn L Marsh; Xuan Qin; Sharon McNamara; Ronald Gibson; Jane L Burns; Gail Deutsch; Lucas R Hoffman
Journal:  Ann Am Thorac Soc       Date:  2014-09

9.  Reagent and laboratory contamination can critically impact sequence-based microbiome analyses.

Authors:  Susannah J Salter; Michael J Cox; Elena M Turek; Szymon T Calus; William O Cookson; Miriam F Moffatt; Paul Turner; Julian Parkhill; Nicholas J Loman; Alan W Walker
Journal:  BMC Biol       Date:  2014-11-12       Impact factor: 7.431

10.  A relationship between Pseudomonal growth behaviour and cystic fibrosis patient lung function identified in a metabolomic investigation.

Authors:  Justyna Kozlowska; Damian W Rivett; Louic S Vermeer; Mary P Carroll; Kenneth D Bruce; A James Mason; Geraint B Rogers
Journal:  Metabolomics       Date:  2013-12       Impact factor: 4.290

View more
  8 in total

Review 1.  The Microbiome and the Respiratory Tract.

Authors:  Robert P Dickson; John R Erb-Downward; Fernando J Martinez; Gary B Huffnagle
Journal:  Annu Rev Physiol       Date:  2015-11-02       Impact factor: 19.318

Review 2.  Rapid ex vivo molecular fingerprinting of biofluids using laser-assisted rapid evaporative ionization mass spectrometry.

Authors:  Vera Plekhova; Lieven Van Meulebroek; Marilyn De Graeve; Alvaro Perdones-Montero; Margot De Spiegeleer; Ellen De Paepe; Emma Van de Walle; Zoltan Takats; Simon J S Cameron; Lynn Vanhaecke
Journal:  Nat Protoc       Date:  2021-08-02       Impact factor: 13.491

Review 3.  Cystic Fibrosis Airway Microbiome: Overturning the Old, Opening the Way for the New.

Authors:  George A O'Toole
Journal:  J Bacteriol       Date:  2018-01-24       Impact factor: 3.490

4.  Reproducible molecular networking of untargeted mass spectrometry data using GNPS.

Authors:  Allegra T Aron; Emily C Gentry; Kerry L McPhail; Louis-Félix Nothias; Mélissa Nothias-Esposito; Amina Bouslimani; Daniel Petras; Julia M Gauglitz; Nicole Sikora; Fernando Vargas; Justin J J van der Hooft; Madeleine Ernst; Kyo Bin Kang; Christine M Aceves; Andrés Mauricio Caraballo-Rodríguez; Irina Koester; Kelly C Weldon; Samuel Bertrand; Catherine Roullier; Kunyang Sun; Richard M Tehan; Cristopher A Boya P; Martin H Christian; Marcelino Gutiérrez; Aldo Moreno Ulloa; Javier Andres Tejeda Mora; Randy Mojica-Flores; Johant Lakey-Beitia; Victor Vásquez-Chaves; Yilue Zhang; Angela I Calderón; Nicole Tayler; Robert A Keyzers; Fidele Tugizimana; Nombuso Ndlovu; Alexander A Aksenov; Alan K Jarmusch; Robin Schmid; Andrew W Truman; Nuno Bandeira; Mingxun Wang; Pieter C Dorrestein
Journal:  Nat Protoc       Date:  2020-05-13       Impact factor: 17.021

5.  Making It Last: Storage Time and Temperature Have Differential Impacts on Metabolite Profiles of Airway Samples from Cystic Fibrosis Patients.

Authors:  Stephen Wandro; Lisa Carmody; Tara Gallagher; John J LiPuma; Katrine Whiteson
Journal:  mSystems       Date:  2017-11-28       Impact factor: 6.496

6.  Lessons learned from metabolomics in cystic fibrosis.

Authors:  Marianne S Muhlebach; Wei Sha
Journal:  Mol Cell Pediatr       Date:  2015-10-20

7.  Culture-Independent Identification of Nontuberculous Mycobacteria in Cystic Fibrosis Respiratory Samples.

Authors:  Lindsay J Caverly; Lisa A Carmody; Sarah-Jane Haig; Nadine Kotlarz; Linda M Kalikin; Lutgarde Raskin; John J LiPuma
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240

Review 8.  Metabolomics and Its Application to Acute Lung Diseases.

Authors:  Kathleen A Stringer; Ryan T McKay; Alla Karnovsky; Bernadette Quémerais; Paige Lacy
Journal:  Front Immunol       Date:  2016-02-29       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.